Approval · Notice of Compliance 8023 · 2006
MARINOL: Notice of Compliance 8023
Issued June 13, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8023
- Date
- June 13, 2006
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update & new product monograph format
- Therapeutic class
- Antiemetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MARINOL | Not yet assigned | — |
Medicinal ingredients
- DRONABINOL 2.5 MG per CAP
- DRONABINOL 5 MG per CAP
- DRONABINOL 10 MG per CAP